- Home
- ADAG vs HEQ Comparison
ADAG vs HEQ Comparison
Compare ADAG & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADAG | HEQ |
|---|---|---|
| Founded | 2011 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.3M | 130.0M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ADAG | HEQ |
|---|---|---|
| Price | $3.81 | $10.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 222.3K | 57.0K |
| Earning Date | 03-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3,688.61 | N/A |
| Revenue Next Year | $17.39 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $9.23 |
| 52 Week High | $4.58 | $11.58 |
Technical Indicators
Market Signals| Indicator | ADAG | HEQ |
|---|---|---|
| Relative Strength Index (RSI) | 56.77 | 38.54 |
| Support Level | $1.69 | $10.51 |
| Resistance Level | $4.58 | $10.80 |
| Average True Range (ATR) | 0.46 | 0.18 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 48.95 | 26.35 |
Price Performance
Historical ComparisonAbout ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest
John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return, with a focus on current income and gains, and to include long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.